Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Skin can heal wounds without hair follicle stem cells, but it takes a bit longer.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

The 3D skin model mimics pemphigus vulgaris and helps test treatments.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Foxp1 helps control hair stem cell growth and response to stress during hair growth cycles.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

STK11 gene polymorphism does not predict metformin response in PCOS.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Oral minoxidil helps female hair loss, topical finasteride treats AGA, and sulfotransferase activity predicts minoxidil effectiveness.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Narrowband UVB therapy significantly improved a child's rare skin condition.

Higher CRHR1 levels in AA patients lead to increased inflammation.

A 3D skin model helps study wound healing better than traditional methods.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Vitamin D receptor is crucial for skin wound healing.